who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

How Intuitive Surgical (ISRG) makes money: Q3 2026 revenue breakdown

US GAAP, Q3 2026 · quarter ended 09/30/2026 · released Oct 20

Net income attributable to Intuitive Surgical, Inc.

$523M

down 25.8% y/y

Total revenue

$3,049M

up 21.7% y/y

Income from operations

$593M

down 22.0% y/y

Next report

~ Jan 21

not announced yet

The quarter in brief

Revenue rose 22% to $3.05 billion, but operating income fell to $593 million from $760 million. GAAP net income fell 26% to $523 million and diluted EPS fell to $1.49 from $1.95.

Key growth driver: Instruments and accessories — the fastest-growing revenue line: $1,797, +18% y/y. · by the Q3 2026 report

How does Intuitive Surgical make money?

Intuitive Surgical brought in $3.05 billion of revenue in Q3 2026, up 21.7% year over year. The largest source was Instruments and accessories: $1.80 billion, or 59% of the total, followed by Systems ($769M, 25%) and Services ($482M, 16%). Net income for the quarter was $523 million, down 25.8% year over year.

Revenue by source, Q3 2026
  • Instruments and accessories$1.80B · 59% · +18.3%
  • Systems$769M · 25% · +30.3%
  • Services$482M · 16% · +21.8%

Shares of $3.05B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.

All figures in $M.

Sankey diagram of ISRG (Intuitive Surgical) earnings report for Q3 2026: revenue, costs and profitInstruments andaccessories$1,797 · +18.3%Systems$769 · +30.3%Services$482 · +21.8%Total revenue$3,049 · +21.7%Cost of revenue:Product$798 · +14.1%Cost of revenue:Service$167 · +16.3%Gross profit$2,084 · +25.4%68.4% marginSelling, general,andadministrative$1,083 · +89.0%Research anddevelopment$408 · +24.0%Income fromoperations$593 · −22.0%19.4% marginInterest andother income, net$75.8 · −20.6%Income beforetaxes$668 · −21.8%Income tax expense$144 · −1.4%21.5% effective rateNet income attributable tononcontrolling interest injoint venture$1.6 · −66.7%Net income attributable toIntuitive Surgical, Inc.$523 · −25.8%$1.49/sh · 17.1% margin
Sankey diagram of ISRG (Intuitive Surgical) earnings report for Q3 2026: revenue, costs and profit
Line itemAmount and change
Instruments and accessories$1,797 · +18.3%
Systems$769 · +30.3%
Services$482 · +21.8%
Total revenue$3,049 · +21.7%
Cost of revenue: Product$798 · +14.1%
Cost of revenue: Service$167 · +16.3%
Gross profit$2,084 · +25.4% · 68.4% margin
Selling, general, and administrative$1,083 · +89.0%
Research and development$408 · +24.0%
Income from operations$593 · −22.0% · 19.4% margin
Interest and other income, net$75.8 · −20.6%
Income before taxes$668 · −21.8%
Income tax expense$144 · −1.4% · 21.5% effective rate
Net income attributable to noncontrolling interest in joint venture$1.6 · −66.7%
Net income attributable to Intuitive Surgical, Inc.$523 · −25.8% · $1.49/sh · 17.1% margin

Verdict: Revenue rose 22% to $3.05 billion, but operating income fell to $593 million from $760 million. GAAP net income fell 26% to $523 million and diluted EPS fell to $1.49 from $1.95.

For 2026 the company expects da Vinci procedure growth of about 14% to 15%, non-GAAP gross margin of 68.7% to 69.3% and non-GAAP operating expense growth of 11% to 13%. The company repurchased 7.8 million shares for $2.94 billion in the quarter. Cash, cash equivalents and investments fell by $1.83 billion to $6.80 billion.

Source and notation

Source: Intuitive Surgical press release, 8-K EX-99.1 of 10/20/2026 (SEC EDGAR).

Open as an image: Intuitive Surgical (ISRG), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “Intuitive Surgical (ISRG) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/isrg. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/isrg"><img src="https://whoreportstoday.com/t/isrg/img/intuitive-surgical-isrg-earnings-sankey.png" alt="Intuitive Surgical (ISRG) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/isrg">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/isrg/img/intuitive-surgical-isrg-earnings-sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/isrg">Intuitive Surgical (ISRG) Q3 2026 earnings chart (Who Reports Today)</a>

The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. · Text: Wikipedia, CC BY-SA 4.0, abridged

The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.

Heads-up

Company reports

Q3 2026latest breakdownRevenue rose 22% to $3.05 billion, but operating income fell to $593 million from $760 million. GAAP net income fell 26%…
Q2 2026A strong quarter with revenue up 19% and GAAP net income up 24%, driven by robust instrument/accessory pull-through from…

Company guidance

Same quarter a year ago (ended December 31, 2025): revenue $2.866B, EPS (GAAP) $2.19

How we calculate

Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.

ISRG earnings history: past report dates

Oct 20, 2026 Tue4:05 pmafter market closeSep 30, 2026$3.0B+22% y/y$1.49−24% y/y
Jul 16, 2026 Thu4:05 pmafter market closeJun 30, 2026$2.9B+19% y/y$2.29+27% y/y
Apr 21, 2026 Tue4:09 pmafter market closeMar 31, 2026$2.8B+23% y/y$2.28+19% y/y
Jan 22, 2026 Thu4:05 pmafter market closeDec 31, 2025≈$2.9B+19% y/y≈$2.19+16% y/y
Oct 21, 2025 Tue4:03 pmafter market closeSep 30, 2025$2.5B+23% y/y$1.95+25% y/y
Jul 22, 2025 Tue4:03 pmafter market closeJun 30, 2025$2.4B+21% y/y$1.81+24% y/y
Apr 22, 2025 Tue4:03 pmafter market closeMar 31, 2025$2.3B+19% y/y$1.92+27% y/y
Jan 23, 2025 Thu4:03 pmafter market closeDec 31, 2024≈$2.4B+25% y/y≈$1.89+12% y/y
Oct 17, 2024 Thu4:02 pmafter market closeSep 30, 2024$2.0B+17% y/y$1.56+34% y/y
Jul 18, 2024 Thu4:03 pmafter market closeJun 30, 2024$2.0B+14% y/y$1.46+24% y/y
Apr 18, 2024 Thu4:04 pmafter market closeMar 31, 2024$1.9B+11% y/y$1.51+51% y/y
Jan 23, 2024 Tue4:02 pmafter market closeDec 31, 2023≈$1.9B+17% y/y≈$1.69+86% y/y
Oct 19, 2023 Thu4:04 pmafter market closeSep 30, 2023$1.7B+12% y/y$1.16+29% y/y
Jul 20, 2023 Thu4:00 pmafter market closeJun 30, 2023$1.8B+15% y/y$1.18+39% y/y
Apr 18, 2023 Tue4:01 pmafter market closeMar 31, 2023$1.7B+14% y/y$1.00+0% y/y
Jan 24, 2023 Tue4:01 pmafter market closeDec 31, 2022≈$1.7B+7% y/y≈$0.91−12% y/y
Show all 16 reports since 2023Show fewer
How we count

Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.

Intuitive Surgical: 15-year financials

202510,0652,9462,8562,491
20248,3522,3492,3231,304
20237,1241,7671,798750
20226,2221,5771,322958
20215,7101,8211,7051,750
20204,3581,0501,0611,143
20194,4791,3751,3791,173
20183,7241,1991,128982
20173,1381,063671953
20162,7079507381,033
20152,384740589725
20142,132545419560
20132,265853671775
20122,179878657700
20111,757695495595

$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.

* Sources
How we calculate

Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.

Intuitive Surgical: 15-year balance sheet

YearAssetsEquityCashCurrent assetsCurrent liabilities
202520,45917,8243,3689,7802,006
202418,74316,4342,0277,1111,745
202315,44213,3082,7507,8881,659
202212,97411,0421,5816,2531,422
202113,55511,9011,2915,8451,150
202011,1699,7321,6236,626965
20199,7338,2641,1684,6631,030
20187,8476,6798584,333821
20175,7774,7796482,809663
20166,4875,7781,0373,250597
20154,9074,3207152,196492
20143,9593,3796001,812501
20133,9503,5017821,932381
20124,0593,5805541,893402
20113,0632,6464661,466321

$ millions, at fiscal year-end*.

* Sources
How we calculate

Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .

Cash flow

9 months ended 2026-09-30 · $M

LineThis periodYear agoΔ
Operating cash flowcash the business generated3,1972,138+1,059
· incl. stock-based comp (non-cash)share-based compensation632585
Capexpurchases of property & equipment−329−377+48.3
Free cash flow ≈operating cash flow − capex2,8681,761+1,107
Investing activities, netcapex, acquisitions, securities957875+81.5
· incl. acquisitionsbusinesses net of cash acquired−519−1.2−517
Financing activities, netdebt, buybacks, dividends−4,535−2,227−2,309
· incl. buybacksrepurchases of common stock−4,419−2,094−2,325
· incl. dividends paid—0
FX effect on cash−3.50.5−4
Net change in cash−385787−1,172
How to read the table

Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.

Shareholders’ equity at Sep 30, 2026: $16.0B (83% of total assets). Compare with other S&P 500 companies →

Corporate governance

2/2good

  • Jun 2018Intuitive Surgical agreed to pay $42.5M to settle a shareholder class action — below the methodology's $50M threshold. sec.gov ↗
  • Feb 2026Per the 2025 10-K, one class of shares; the notes list no pending shareholder disclosure suits or SEC cases. sec.gov ↗
1 more fact and scoring

How the company treats minority shareholders: 2 — well, 0 — systematically poorly.

  • Dec 2025Diluted share count 2020→2025 +0.5%; SBC is 7.8% of revenue (XBRL 10-K). data.sec.gov ↗

Scoring: 2.0, no deductions = 2.0

Share classes
Single class of common stock (10-K cover).
Dilution
Diluted share count 2020→2025 +0.5%; SBC 7.8% of revenue (<10%); buybacks of $2.6B in 2022 and $2.3B in 2025.
Disclosure
10-Ks and 10-Qs filed on time, audited US GAAP financials; no deduction.
Dividends
Pays no dividends and has not promised any — no deduction.
Lawsuits & regulators
The 2013 shareholder class action was settled in 2018 for $42.5M — below the $50M threshold, no deduction; the 10-K shows no new shareholder suits or SEC cases.
Related parties
No non-arm's-length related-party transactions.

How the score works · checked as of Oct 2026

Intuitive Surgical (ISRG) earnings: FAQ

How does Intuitive Surgical make money?

Intuitive Surgical brought in $3.05 billion of revenue in Q3 2026, up 21.7% year over year. The largest source was Instruments and accessories: $1.80 billion, or 59% of the total, followed by Systems ($769M, 25%) and Services ($482M, 16%). Net income for the quarter was $523 million, down 25.8% year over year.

When is ISRG's next earnings date?

We have not yet seen an announcement of the date from Intuitive Surgical (ISRG). Based on last year's report on Jan 22, 2026, the next report is expected around Jan 21, 2027.

What time does ISRG report earnings?

Intuitive Surgical usually reports after market close: its latest results release was filed with the SEC at 4:05 pm ET on Oct 20, 2026.

When did ISRG last report earnings?

Intuitive Surgical reported Q3 2026 results on Oct 20, 2026.

Where can I find Intuitive Surgical's financial statements?

On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to ISRG's filings; this page breaks the latest report down in a Sankey chart.

What was ISRG's net income in Q3 2026?

Intuitive Surgical reported net income of $523M for Q3 2026 (−25.8% year over year), under US GAAP.

How has Intuitive Surgical's revenue changed since 2011?

Per its 10-K filings, revenue grew 5.7x: $1,757M in 2011 and $10,065M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.

New to earnings reports? Start with how to read an earnings report.

Get it every Monday: who reports this week

Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.

Only dates announced by companies. No stock prices. Not investment advice.

More reports: JNJ · Q3 2026 · LH · Q3 2026 · LLY · Q3 2026 · MCK · Q1 FY2027 · MDT · Q1 2027 · MRK · Q3 2026 · MRNA · Q2 2026 · MTD · Q3 2026 · PFE · Q3 2026 · PODD · Q3 2026 · all reports

Cookies the site needs and, with your consent, Google Analytics — privacy policy